Carlos
Alfaro Alegría
Investigador ata 2017
University of California, Berkeley
Berkeley, Estados UnidosPublicacións en colaboración con investigadores/as de University of California, Berkeley (1)
2007
-
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ
International Journal of Cancer, Vol. 121, Núm. 6, pp. 1282-1295